Skip to main content
Premium Trial:

Request an Annual Quote

Tim Tasker, Daniel Bradbury, John Stuelpnagel, Ibidi, Max Planck Institute for Biochemistry



Evotec has appointed Tim Tasker as executive vice president of clinical development and a member of the executive committee, the Hamburg, Germany-based drug-discovery firm said last week.

Tasker will join Evotec July 11. Tasker most recently served as vice president of global clinical units, clinical pharmacology, and discovery medicine at GlaxoSmithKline. He holds a BA in physiological sciences from the University of Oxford and an MD from London University.

Daniel Bradbury and John Stuelpnagel have been reelected to Illumina's board of directors, following the company's annual meeting of stockholders held in San Diego two weeks ago. Bradbury serves as chief operating officer of Amylin Pharmaceuticals, and Stuelpnagel is senior vice president and COO of Illumina.


Ibidi has launched a new chemotaxis assay based on the company's u-Slides microscopy carriers, ibidi said last week.

The assay allows real-time imaging of fast-moving cells during incubation with a chemoattractant, ibidi said.

The development was carried out in collaboration with the Max Planck Institute for Biochemistry in Martinsried, Germany, and first results from experiments using the assay were published in the May issue of American Biotechnology Laboratory. Ibidi said it plans to develop parallel assays for following slower cell types, such as cancer cells and primary cells.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.